Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Revelation Biosciences Q2 EPS $(0.12)

Revelation Biosciences Q2 EPS $(0.12)

Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(0.12) per share.

byMichael Horton

August 15, 2022

1 minute read

Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(0.12) per share.

USDT Issuer Tether Launches New Gold-Backed USD-Pegged Stablecoin In Latest Tokenization Push

By Aniket Verma

June 18, 1:33 AM

Stablecoin issuing company Tether (CRYPTO: USDT) launched a new platform Monday that will allow the creation of gold-backed stablecoins pegged to the U.S. Dollar.

$USDT

Earnings

Preview: Renalytix AI’s Earnings

By Benzinga Insights

November 29, 11:05 AM

Renalytix AI (NASDAQ:RNLX) is set to give its latest quarterly earnings report on Wednesday, 2022-11-30. Here’s what investors…

RNLX

Earnings

A Preview Of Barclays’s Earnings

By Benzinga Insights

February 19, 10:00 AM

Barclays (NYSE:BCS) is set to give its latest quarterly earnings report on Tuesday, 2024-02-20. Here’s what investors need…

BCS

These Analysts Revise Their Forecasts On Lowe’s After Q2 Results

By Lisa Levin

August 23, 9:48 AM

Lowe's Companies Inc (NYSE: LOW) reported better-than-expected second-quarter earnings and reaffirmed FY23 outlook.

LOW

Revelation Biosciences Q2 EPS $(0.12)

Related Posts

USDT Issuer Tether Launches New Gold-Backed USD-Pegged Stablecoin In Latest Tokenization Push

Preview: Renalytix AI’s Earnings

A Preview Of Barclays’s Earnings

These Analysts Revise Their Forecasts On Lowe’s After Q2 Results